Literature DB >> 11552790

Evaluation of thermal therapy in a prostate cancer model using a wet electrode radiofrequency probe.

S Bhowmick1, D J Swanlund, J E Coad, L Lulloff, M F Hoey, J C Bischof.   

Abstract

PURPOSE: To determine the temperature-time threshold of local cell death in vivo for thermal therapy in a prostate cancer animal model and to use this value as a benchmark to quantify global tissue injury.
MATERIALS AND METHODS: Two studies were designed in the Dunning AT-1 rat prostate tumor hind limb model. For both studies, a wet electrode radiofrequency (RF) probe was used to deliver 40 W of energy for 18 to 62 seconds after a 30-second infusion of hypertonic saline/Hypaque through the RF antenna. Thermal history measurements were obtained in tumors from at least two Fluoroptic probes placed radially 5 mm from the axis of a RF probe and 10 mm below the surface of the tissue. In study 1, the thermal history required for irreversible cell injury was experimentally determined by comparing the predicted injury accumulation (omega) with cell viability at the fluoroptic probe locations using an in vivo-in vitro assay. The omega value was calculated from the measured thermal histories using an Arrhenius damage model. In study 2, RF energy was applied for 40 seconds in all cases. At 1, 3, and 7 days after thermal therapy, triphenyltetrazolium chloride dye (TTC) and histologic analyses were performed to assess global tissue injury within a 5-mm radius from the axis of the RF probe.
RESULTS: Study 1 showed that cell survival dropped to 0 for 0.42 < omega < 0.7. This result was the basis for selection of 40 seconds of RF thermal therapy in study 2, which yielded omegaave = 0.5 in the tissue 5 mm from the probe axis. Both TTC and histology analysis showed that sham-treated tissue was not irreversibly injured. However, there was an inherent heterogeneity present in the tumor that accounted for as much as 15% necrosis in control or sham-treated tissue. In contrast, at 1, 3, and 7 days after therapy, significantly less enzyme activity was observed by TCC in thermally treated tissue compared with sham-treated tissue (35 v 85%; P < 0.001). Histologic analysis of thermally treated tissues revealed a gradual increase in the percent of coagulative necrosis (47%-70%) with a concomitant decrease in the percentage of shocked cells (53%-28%). At day 7, <3% viability was observed in treated tumors compared with 90% viability in sham-treated tissue.
CONCLUSION: The threshold of cellular injury in vivo corresponded to omega > 0.7 (> or =48 degrees C for 40 seconds). Global tissue injury could be conservatively predicted on the basis of local thermal histories during therapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11552790     DOI: 10.1089/089277901750426436

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  10 in total

Review 1.  Results of radiofrequency kidney tumor ablation: renal function preservation and oncologic efficacy.

Authors:  Nelson Salas; Rajan Ramanathan; Scott Dummett; Raymond J Leveillee
Journal:  World J Urol       Date:  2010-05-09       Impact factor: 4.226

2.  Treatment of advanced non-small cell lung cancer with extracorporeal high frequency thermotherapy combined with Chinese medicine.

Authors:  Wan-yin Wu; Xiao-bing Yang; Hong Deng; Shun-qin Long; Liang-sheng Sun; Wen-feng He; Yu-shu Zhou; Gui-ya Liao; Sai-man Chan; Shi-pu Shan
Journal:  Chin J Integr Med       Date:  2010-09-25       Impact factor: 1.978

3.  Identifying Quantitative In Vivo Multi-Parametric MRI Features For Treatment Related Changes after Laser Interstitial Thermal Therapy of Prostate Cancer.

Authors:  Satish Viswanath; Robert Toth; Mirabela Rusu; Dan Sperling; Herbert Lepor; Jurgen Futterer; Anant Madabhushi
Journal:  Neurocomputing       Date:  2014-11-20       Impact factor: 5.719

4.  Residual tumor after laser ablation of human non-small-cell lung cancer demonstrated by ex vivo staining: correlation with invasive temperature measurements.

Authors:  Christian Oliver Martin Hoffmann; Christian Rosenberg; Albert Linder; Norbert Hosten
Journal:  MAGMA       Date:  2011-06-09       Impact factor: 2.310

Review 5.  Nanoparticle-mediated thermal therapy: evolving strategies for prostate cancer therapy.

Authors:  Sunil Krishnan; Parmeswaran Diagaradjane; Sang Hyun Cho
Journal:  Int J Hyperthermia       Date:  2010-09-21       Impact factor: 3.914

6.  Ablative therapies for renal tumors.

Authors:  Rajan Ramanathan; Raymond J Leveillee
Journal:  Ther Adv Urol       Date:  2010-04

7.  Dead or alive? Autofluorescence distinguishes heat-fixed from viable cells.

Authors:  Leah Hennings; Yihong Kaufmann; Robert Griffin; Eric Siegel; Petr Novak; Peter Corry; Eduardo G Moros; Gal Shafirstein
Journal:  Int J Hyperthermia       Date:  2009-08       Impact factor: 3.914

Review 8.  The prostate cancer focal therapy.

Authors:  Filippo Pesapane; Francesca Patella; Enrico Maria Fumarola; Edoardo Zanchetta; Chiara Floridi; Gianpaolo Carrafiello; Chloë Standaert
Journal:  Gland Surg       Date:  2018-04

9.  Focal laser ablation of prostate cancer: definition, needs, and future.

Authors:  Pierre Colin; Serge Mordon; Pierre Nevoux; Mohammed Feras Marqa; Adil Ouzzane; Philippe Puech; Gregory Bozzini; Bertrand Leroux; Arnauld Villers; Nacim Betrouni
Journal:  Adv Urol       Date:  2012-05-16

10.  Focal laser ablation of prostate cancer: numerical simulation of temperature and damage distribution.

Authors:  Mohamad-Feras Marqa; Pierre Colin; Pierre Nevoux; Serge R Mordon; Nacim Betrouni
Journal:  Biomed Eng Online       Date:  2011-06-02       Impact factor: 2.819

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.